Abstract
Recently, it has been postulated that long-term use of beta blockers might decrease the risk of certain types of cancer because of weakening of norepinephrine signaling. Previous studies on colorectal cancer (CRC) yielded inconsistent results, but lacked information on covariates. Thus, the authors investigated the association of beta blocker use and CRC risk in a large population-based case-control study (DACHS study). Between 2003 and 2007, information on beta blocker use and potential confounders was collected by personal interviews for 1762 CRC cases and 1708 control individuals from Germany. The association of CRC risk and beta blocker use and subclasses of beta blockers was estimated by multiple logistic regression. In addition, site- and stage-specific analyses were performed. After adjustment for covariates, no association was observed with beta blocker use (odds ratio [OR], 1.05; 95% confidence interval [CI], 0.86-1.29) or with duration of beta blocker use. Also, the analysis by subclasses of beta blockers (cardioselectivity) and active ingredients (metoprolol, bisoprolol, carvedilol, and atenolol) or by CRC subsite showed no associations. In stage-specific analyses, long-term beta blocker use (6+ years) was associated...Continue Reading
References
Jul 3, 1976·Lancet·B ArmstrongR Doll
Jul 1, 1992·Cancer Causes & Control : CCC·M McCredie, J H Stewart
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jan 1, 1989·Journal of Clinical Epidemiology·W D FlandersJ R Boring
Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Jan 1, 1986·Journal of Chronic Diseases·A R FeinsteinR I Horwitz
Jul 1, 1996·American Journal of Hypertension·M PahorR J Havlik
Aug 12, 1998·Statistics in Medicine·F Y HsiehM D Larsen
Jun 3, 1999·Drugs·M KornitzerG De Backer
Apr 18, 2002·The American Journal of Medicine·Ehud GrossmanUri Goldbourt
Sep 26, 2003·Cancer·Christopher I LiJanet R Daling
Apr 27, 2004·Revue D'épidémiologie Et De Santé Publique·M AlgaziM G Lê
Jul 29, 2004·Cancer Causes & Control : CCC·Linda PerronFrançois Meyer
Sep 18, 2007·The Journal of Urology·Andrew M HarrisNatasha Kyprianou
Sep 28, 2007·Current Pharmaceutical Design·Patrick K Y GoonGregory Y H Lip
Jan 5, 2008·American Journal of Hypertension·Ruben O HalperinHoward D Sesso
Sep 10, 2008·Pharmacoepidemiology and Drug Safety·Themistocles L AssimesSamy Suissa
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Paul J Fitzgerald
Jan 15, 2009·International Journal of Cancer. Journal International Du Cancer·Peter S LiangEdward Giovannucci
Feb 12, 2009·British Journal of Cancer·K Y WolinI-M Lee
Jun 23, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Y NingE L Giovannucci
Jul 8, 2009·Cancer Causes & Control : CCC·Gary D FriedmanLaurel A Habel
Jul 17, 2009·Clinical Pharmacology and Therapeutics·M HoffmeisterH Brenner
Oct 16, 2009·Journal of Hypertension·Au Bich ThuyTerence Dwyer
Mar 25, 2010·International Journal of Cancer. Journal International Du Cancer·Gary D FriedmanLaurel A Habel
Jun 8, 2010·Cancer Causes & Control : CCC·Joan A LargentHoda Anton-Culver
Dec 3, 2010·The Lancet Oncology·Sripal BangaloreFranz H Messerli
Jan 5, 2011·Annals of Internal Medicine·Hermann BrennerMichael Hoffmeister
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amal Melhem-BertrandtAna-Maria Gonzalez-Angulo
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas I BarronKala Visvanathan
Citations
Aug 6, 2013·Breast Cancer Research and Treatment·Edoardo BotteriSara Gandini
Jul 19, 2012·Clinical Epidemiology·Paul J Fitzgerald
Dec 12, 2012·OncoTargets and Therapy·Yi JiKai Li
Dec 20, 2012·Expert Review of Anticancer Therapy·Vincenzo De GiorgiPierangelo Geppetti
Feb 2, 2013·Current Medical Research and Opinion·Matteo MonamiEdoardo Mannucci
Feb 24, 2015·International Journal of Cardiology·Chin-Sheng LinChia-Hung Kao
Nov 5, 2013·Mayo Clinic Proceedings·Manish Kohli
Sep 12, 2015·Journal of Digestive Diseases·Yoshitaka WatanabeKazuhiko Koike
Dec 15, 2015·Pharmacogenomics·Ruo-Hui HeJie Liu
Jan 3, 2013·Cancer·Yang YangNestor F Esnaola
Jan 15, 2014·Cancer·Lina JansenHermann Brenner
Jun 21, 2013·International Journal of Cancer. Journal International Du Cancer·Alberto MilanFranco Veglio
Apr 8, 2016·Journal of Anesthesia·Kazuyoshi Hirota
Dec 19, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Shahid Akbar, Mansour Saleh Alsharidah
Dec 20, 2014·Medicinal Research Reviews·Luca FilippiPaola Bagnoli
Jul 15, 2015·Medicine·Ping-Ying ChangChia-Hung Kao
May 21, 2015·Journal of Pharmaceutical Policy and Practice·Rawan SaadehAkihiro Seita
Apr 15, 2015·BMJ Open·David A SpringateDavid Reeves
Mar 15, 2015·Journal of the National Cancer Institute·Michael HoffmeisterHermann Brenner
Jul 28, 2019·Epidemiology·Phyo T HtooJennifer L Lund
Sep 19, 2019·Oncogene·Shu-Heng JiangZhi-Gang Zhang
Oct 7, 2016·Oncotarget·Hye-Young MinHo-Young Lee
Dec 10, 2015·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Beade NumbereTimothy R Card
Mar 11, 2020·Cardio-Oncology·Neha BansalSteven E Lipshultz
Jun 26, 2020·Scientific Reports·Jae-Hyun SeoYoung-Hoon Joo
Jun 18, 2015·Oncotarget·Jie YouMing-Hua Zheng
Nov 22, 2012·Experimental and Therapeutic Medicine·Jessica StilesBrad A Bryan
Jun 14, 2019·Medicine·Min-Su KimSoon Young Kwon
May 17, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Joel N SwerdelJohn B Kostis
Jun 13, 2020·American Journal of Hypertension·Elias SanidasJohn Barbetseas
Jul 10, 2021·PloS One·Jihye ParkDong Ho Lee